These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2158421)
1. [A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]. Benavides J; Depoortere H; Sanger D; Perrault G; Arbilla S; Langer SZ; Zivkovic B; Scatton B Encephale; 1990; 16(1):13-22. PubMed ID: 2158421 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent]. Shirakawa K Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759 [TBL] [Abstract][Full Text] [Related]
3. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178 [TBL] [Abstract][Full Text] [Related]
4. [Contribution of zolpidem in the management of sleep disorders]. Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P Encephale; 1992; 18(4):379-92. PubMed ID: 1363657 [TBL] [Abstract][Full Text] [Related]
5. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Perrault G; Morel E; Sanger DJ; Zivkovic B Eur J Pharmacol; 1990 Oct; 187(3):487-94. PubMed ID: 1981555 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. Benavides J; Peny B; Durand A; Arbilla S; Scatton B J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419 [TBL] [Abstract][Full Text] [Related]
7. Specificity within the GABAA receptor supramolecular complex: a consideration of the new omega 1-receptor selective imidazopyridine hypnotic zolpidem. Lloyd KG; Zivkovic B Pharmacol Biochem Behav; 1988 Apr; 29(4):781-3. PubMed ID: 2842810 [TBL] [Abstract][Full Text] [Related]
8. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Benavides J; Peny B; Ruano D; Vitorica J; Scatton B Brain Res; 1993 Feb; 604(1-2):240-50. PubMed ID: 8096157 [TBL] [Abstract][Full Text] [Related]
9. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599 [TBL] [Abstract][Full Text] [Related]
10. The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem. Perrault G; Morel E; Sanger DJ; Zivkovic B Eur J Pharmacol; 1988 Nov; 156(2):189-96. PubMed ID: 2853673 [TBL] [Abstract][Full Text] [Related]
11. The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure. Sanger DJ; Perrault G; Morel E; Joly D; Zivkovic B Physiol Behav; 1987; 41(3):235-40. PubMed ID: 3324120 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the hypnotic zolpidem in vivo. Crestani F; Martin JR; Möhler H; Rudolph U Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095 [TBL] [Abstract][Full Text] [Related]
13. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes. Lloyd GK; Danielou G; Thuret F J Pharmacol Exp Ther; 1990 Nov; 255(2):690-6. PubMed ID: 2173755 [TBL] [Abstract][Full Text] [Related]
14. Zolpidem functionally discriminates subtypes of native GABAA receptors in acutely dissociated rat striatal and cerebellar neurons. Itier V; Depoortere H; Scatton B; Avenet P Neuropharmacology; 1996 Feb; 35(2):137-45. PubMed ID: 8734481 [TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. Rowlett JK; Spealman RD; Lelas S J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847 [TBL] [Abstract][Full Text] [Related]
16. Differences in enhancing effects of zolpidem and benzodiazepine drugs on recurrent inhibition in rat hippocampal slices. Higashima M; Kinoshita H; Yamaguchi N; Koshino Y Psychopharmacology (Berl); 1997 Jun; 131(4):394-8. PubMed ID: 9226742 [TBL] [Abstract][Full Text] [Related]
17. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. Dennis T; Dubois A; Benavides J; Scatton B J Pharmacol Exp Ther; 1988 Oct; 247(1):309-22. PubMed ID: 2845057 [TBL] [Abstract][Full Text] [Related]
18. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation. Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065 [TBL] [Abstract][Full Text] [Related]
19. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. Sanger DJ CNS Drugs; 2004; 18 Suppl 1():9-15; discussion 41, 43-5. PubMed ID: 15291009 [TBL] [Abstract][Full Text] [Related]